- Home
- LCW vs ME Comparison
LCW vs ME Comparison
Compare LCW & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCW
- ME
- Stock Information
- Founded
- LCW 2021
- ME 2006
- Country
- LCW United States
- ME United States
- Employees
- LCW N/A
- ME N/A
- Industry
- LCW Blank Checks
- ME Precision Instruments
- Sector
- LCW Finance
- ME Health Care
- Exchange
- LCW Nasdaq
- ME Nasdaq
- Market Cap
- LCW 165.8M
- ME 168.9M
- IPO Year
- LCW 2021
- ME N/A
- Fundamental
- Price
- LCW $11.00
- ME $0.30
- Analyst Decision
- LCW
- ME Hold
- Analyst Count
- LCW 0
- ME 1
- Target Price
- LCW N/A
- ME $0.47
- AVG Volume (30 Days)
- LCW 25.5K
- ME 2.8M
- Earning Date
- LCW 01-01-0001
- ME 08-08-2024
- Dividend Yield
- LCW N/A
- ME N/A
- EPS Growth
- LCW N/A
- ME N/A
- EPS
- LCW N/A
- ME N/A
- Revenue
- LCW N/A
- ME $199,188,000.00
- Revenue This Year
- LCW N/A
- ME $0.05
- Revenue Next Year
- LCW N/A
- ME $17.98
- P/E Ratio
- LCW N/A
- ME N/A
- Revenue Growth
- LCW N/A
- ME N/A
- 52 Week Low
- LCW $10.57
- ME $0.30
- 52 Week High
- LCW $11.03
- ME $1.16
- Technical
- Relative Strength Index (RSI)
- LCW 59.38
- ME 35.07
- Support Level
- LCW $11.00
- ME $0.30
- Resistance Level
- LCW $11.02
- ME $0.32
- Average True Range (ATR)
- LCW 0.01
- ME 0.02
- MACD
- LCW -0.00
- ME 0.00
- Stochastic Oscillator
- LCW 60.00
- ME 5.43
About LCW Learn CW Investment Corporation
Learn CW Investment Corp is a blank check company. It is formed for the purpose of effecting a merger, consolidation, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.